Cytokine gene expression in pancreatic islet grafts in the rat

Transplantation

Volumn 64, Issue 8, 1997, Pages 1152-1159

  Ozasa, Takao ^a   Newton, Mary R ^a   Dallman, Margaret J ^a,b   Shimizu, Shinichi ^a   Gray, Derek W R ^a   Morris, Peter J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 6;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; GENE EXPRESSION; GRAFT REJECTION; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; NONHUMAN; PANCREAS DISEASE; PANCREAS TRANSPLANTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT;

ANIMALS; CYTOKINES; GENE EXPRESSION; INTERFERON TYPE II; INTERLEUKIN-1; INTERLEUKIN-10; INTERLEUKIN-2; INTERLEUKIN-6; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; RATS; RATS, INBRED LEW; RATS, INBRED STRAINS; RNA, MESSENGER; TRANSPLANTATION, HOMOLOGOUS; TRANSPLANTATION, ISOGENEIC;

EID: 0030724028     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199710270-00013     Document Type: Article

References (47)

1. Warnock GL, Kneteman NM, Ryan EA, Rabinovitch A, Rajotte RV. Long-term follow-up after transplantation of insulin-producing pancreatic islets into patients with type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1992; 35: 89.
2. Ricordi C, Tzakis AG, Carroll PB, et al. Human islet isolation and allotransplantation in 22 consecutive cases. Transplantation 1992; 53: 407.
3. Sutherland DE. Pancreas and islet transplantation. I. Experimental studies. Diabetologia 1981; 20: 161.
4. Kaufman DB, Platt JL, Rabe FL, Dunn DL, Bach FH, Sutherland DE. Differential roles of Mac-1+ cells, and CD4+ and CD8+ T lymphocytes in primary nonfunction and classic rejection of islet allografts. J Exp Med 1990; 172: 291.
5. Dallman MJ, Larsen CP, Morris PJ. Cytokine gene transcription in vascularised organ grafts: analysis using semiquantitative polymerase chain reaction. J Exp Med 1991; 174: 493.
6. Mandrup-Poulsen T, Bendtzen K, Nerup J, Dinarello CA, Svenson M, Nielsen JH. Affinity-purified human interleukin I is cytotoxic to isolated islets of Langerhans. Diabetologia 1986; 29: 63.
7. Rabinovitch A, Pukel C, Baquerizo H. Interleukin-1 inhibits glucose-modulated insulin and glucagon secretion in rat islet monolayer cultures. Endocrinology 1988; 122: 2393.
8. 2+ uptake by islets of Langerhans. FEBS Lett 1989; 248: 35.
9. Mandrup-Poulsen T, Helqvist S, Molvig J, Wogensen LD, Nerup J. Cytokines as immune effector molecules in autoimmune endocrine diseases with special reference to insulin-dependent diabetes mellitus. Autoimmunity 1989; 4: 191.
10. Reece-Smith H, DuToit DF, McShane P, Morris PJ. Prolonged survival of pancreatic islet allografts transplanted beneath the renal capsule. Transplantation 1981; 31: 305.
11. O'Connell PJ, Pacheco-Silva A, Nickerson PW, et al. Unmodified pancreatic islet allograft rejection results in the preferential expression of certain T cell activation transcripts. J Immunol 1993; 150: 1093.
12. Sutton R, Peters M, McShane P, Gray DWR, Morris PJ. Isolation of rat pancreatic islets by ductal injection of collagenase. Transplantation 1986; 42: 689.
13. Lake SP, Anderson J, Chamberlain J, Gardner SJ, Bell PR, James RF. Bovine serum albumin density gradient isolation of rat pancreatic islets. Transplantation 1987; 43: 805.
14. Latif ZA, Noel J, Alejandro R. A simple method of staining fresh and cultured islets. Transplantation 1988; 45: 827.
15. Ricordi C, Gray DWR, Hering BJ, et al. Islet isolation assessment in man and large animals. Acta Diabetol Lat 1990; 27: 185.
16. Gray DW, McShane P, Morris PJ. The effect of hyperglycemia on isolated rodent islets transplanted to the kidney capsule site. Transplantation 1986; 41: 699.
17. Dallman MJ, Shiho O, Page TH, Wood KJ, Morris PJ. Peripheral tolerance to alloantigen results from altered regulation of the interleukin 2 pathway. J Exp Med 1991; 173: 79.
18. Mandrup-Poulsen T, Bendtzen K, Dinarello CA, Nerup J. Human tumor necrosis factor potentiates human interleukin 1-mediated rat pancreatic B-cell cytotoxicity. J Immunol 1987; 139: 4077.
19. Campbell IL, Iscaro A, Harrison LC. IFN-gamma and tumor necrosis factor-alpha: cytotoxicity to murine islets of Langerhans. J Immunol 1988; 141: 2325.
20. Sandler S, Bendtzen K, Borg LA, Eizirik DL, Strandell E, Welsh N. Studies on the mechanisms causing inhibition of insulin secretion in rat pancreatic islets exposed to human interleukin-1B indicate a perturbation in the mitochondrial function. Endocrinology 1989; 124: 1492.
21. Rabinovitch A, Sumoski W, Rajotte RV, Warnock GL. Cytotoxic effects of cytokines on human pancreatic islet cells in monolayer culture. J Clin Endocrinol Metab 1990; 71: 152.
22. Baquerizo H, Rabinovitch A. Interferon-gamma sensitizes rat pancreatic islet cells to lysis by cytokines and cytotoxic cells. J Autoimmun 1990; 3 (suppl): 123.
23. Southern C, Schulster D, Green IC. Inhibition of insulin secretion by interleukin-1 beta and tumour necrosis factor-x via an L-arginine-dependent nitric oxide generating mechanism. FEBS Lett 1990; 276: 42.
24. Dallman MJ. The cytokine network and regulation of the immune response to organ transplants. Transplant Rev 1992; 6: 209.
25. Kaufman DB, Rabe F, Platt JL, Stock PG, Sutherland DE. On the variability of outcome after islet allotransplantation. Transplantation 1988; 45: 1151.
26. Dallman MJ, Wood KJ, Hamano K, et al. Cytokines and peripheral tolerance to alloantigen. Immunol Rev 1993; 133: 5.
27. Yamada K, Takane N, Otabe S, Inada C, Inoue M, Nonaka K. Pancreatic beta-cell-selective production of tumor necrosis factor-alpha induced by interleukin-1. Diabetes 1993; 42: 1026.
28. Rabinovitch A, Baquerizo H, Pukel C, Sumoski W. Effects of cytokines on rat pancreatic islet cell monolayer cultures: distinction between functional and cytotoxic effects on islet B-cells. Reg Immunol 1989; 2: 77.
29. Beutler B, Krochin N, Milsark IW, Luedke C, Cerami A. Control of cachectin (tumour necrosis factor) synthesis: mechanisms of endotoxin resistance. Science 1986; 232: 977.
30. Nash JR, Bell PR. Effect of macrophage suppression on the survival of islet allografts. Transplant Proc 1979; 11: 986.
31. Nash JR, Bell PR. Islet transplantation: synergism between antilymphocyte and antimacrophage agents. J Surg Res 1984; 36: 154.
32. Smith KA, Lachman LB, Oppenheim JJ, Favata MF. The functional relationship of the interleukins. J Exp Med 1980; 151: 1551.
33. Dallman MJ, Roake J, Hiughes D, Toogood G, Morris PJ. Sequential analysis of IL-2 gene transcription in renal transplants. Transplantation 1992; 53: 683.
34. Martinez OM, Villanueva JC, Roberts JP, Ascher NL, Krams SM. IL-2 and IL-5 gene expression in response to alloantigen in liver allograft recipients and in vitro. Transplantation 1993; 55: 1159.
35. Wu CJ, Lovett M, Wong-Lee J, et al. Cytokine gene expression in rejecting cardiac alografts. Transplantation 1992; 54: 326.
36. Morgan CJ, Pelletier RP, Hernandez CJ, et al. Alloantigen-dependent endothelial phenotype and lymphokine mRNA expresion in rejecting murine cardiac allografts. Transplantation 1993; 55: 919.
37. Francalancia NA, Wang SC, Thai NL, et al. Graft cytokine mRNA activity in rat single lung transplants by reverse transcription-polymerase chan reaction: effect of cyclosporin. J Heart Lung Transplant 1992; 11: 1041.
38. Kupiec-Weglinski JW, Diamantstein T, Tilney NL. Interleukin 2 receptor-targeted therapy- rationale and applications in organ transplantation. Transplantation 1988; 46: 785.
39. Hahn HJ, Kuttler B, Kloting I, Dunger A, Besch W, Diamantstein T. Extended survival of MHC-identical allogeneic islet grafts in diabetic BB rats: the effect of an interleukin 2 receptor-targeted immunotherapy. Transplantation 1992; 54: 555.
40. Campbell IL, Oxbrow L, West J, Harrison LC. Regulation of MHC protein expression in pancreatic B-cells by interferon-gamma and tumor necrosis factor-alpha. Mol Endocrinol 1988; 2: 101.
41. Hao L, Wang Y, Gill RG, La Rosa FG, Talmage DW, Lafferty KJ. Role of lymphokine in islet allograft rejection. Transplantation 1990; 49: 609.
42. Faustman D, Coe C. Prevention of xenograft rejection by masking donor HLA class I antigens. Science 1991; 252: 1700.
43. Faustman D, Hauptfeld V, Lacy P, Davie J. Prolongation of murine islet allograft survival by pretreatment of islets with antibody directed to Ia determinants. Proc Natl Acad Sci USA 1981; 78: 5156.
44. Pujol-Borrell R, Todd I, Doshi M, et al. HLA class II induction in human islet cells by interferon-y plus tumour necrosis factor or lymphotoxin. Nature 1987; 326: 304.
45. Warren HS, Hodder MJ, Allan W, Hume DA, Simeonovic CJ. Induction of class II major histocompatibility antigens on thyroid, adult pancreatic islet, and fetal proislet allografts. Transplantation 1992; 53: 834.
46. Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989; 7: 145.
47. Campbell IL, Cutri A, Wilson A, Harrison LC. Evidence for IL-6 production by and effects on the pancreatic B cell. J Immunol 1989; 143: 1188.